T
Tarsus Pharmaceuticals D
D
TARS
40.640
USD
-0.43
(-1.03%)
مغلق
حجم التداول
33,250
الربح لكل سهم
-1
العائد الربحي
-
P/E
-15
حجم السوق
1,707,458,592
العنوان: Tarsus Pharmaceuticals
القطاع: Healthcare
الصناعة: Biotechnology
Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis.